Beryl Drugs Limited (BOM:524606)
India · Delayed Price · Currency is INR 22.90
-0.60 (-2.55%)
At close: Jun 17, 2026
Beryl Drugs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 4.25 | 5.79 | 7.69 | 7.66 | -6.59 |
Depreciation & Amortization | 14.93 | 12.46 | 12 | 8.14 | 10.87 |
Other Amortization | - | 0 | 0 | - | - |
Loss (Gain) From Sale of Assets | - | - | -0.11 | - | - |
Other Operating Activities | 2.14 | 5.03 | 3.77 | 4.65 | -0.43 |
Change in Accounts Receivable | 33.69 | 21.27 | -6.84 | -24.52 | 0.92 |
Change in Inventory | -12.24 | -6.43 | -2.06 | 19.24 | -7.09 |
Change in Accounts Payable | 3.1 | -9.01 | -12.32 | 1.91 | -0.47 |
Change in Other Net Operating Assets | -9.38 | -2.75 | 6.06 | 6.83 | -1.89 |
Operating Cash Flow | 36.5 | 26.37 | 8.2 | 23.91 | -4.69 |
Operating Cash Flow Growth | 38.42% | 221.46% | -65.70% | - | - |
Capital Expenditures | -38.24 | -21.85 | -13.52 | -15.64 | -4.16 |
Sale of Property, Plant & Equipment | - | - | 0.21 | - | - |
Sale (Purchase) of Real Estate | -0.29 | - | - | - | - |
Investment in Securities | - | - | 2.19 | - | - |
Other Investing Activities | 16.9 | 17.88 | 0.3 | 3.86 | 9.4 |
Investing Cash Flow | -21.63 | -3.97 | -10.82 | -11.77 | 5.24 |
Short-Term Debt Issued | 3.69 | - | 7.97 | - | 4.81 |
Long-Term Debt Issued | - | 12.48 | - | 11.52 | 16.75 |
Total Debt Issued | 3.69 | 12.48 | 7.97 | 11.52 | 21.56 |
Short-Term Debt Repaid | - | -3.62 | - | -17.84 | - |
Long-Term Debt Repaid | -20.52 | -19.07 | -2.45 | -1.2 | -19.86 |
Total Debt Repaid | -20.52 | -22.69 | -2.45 | -19.04 | -19.86 |
Net Debt Issued (Repaid) | -16.83 | -10.21 | 5.52 | -7.52 | 1.7 |
Other Financing Activities | -3.44 | -5.3 | -4.49 | -4.51 | -4.06 |
Financing Cash Flow | -20.27 | -15.5 | 1.03 | -12.02 | -2.36 |
Miscellaneous Cash Flow Adjustments | -0 | - | 0 | 0 | - |
Net Cash Flow | -5.41 | 6.89 | -1.58 | 0.12 | -1.81 |
Free Cash Flow | -1.75 | 4.52 | -5.31 | 8.28 | -8.84 |
Free Cash Flow Margin | -0.93% | 2.14% | -1.99% | 3.08% | -6.05% |
Free Cash Flow Per Share | -0.34 | 0.89 | -1.05 | 1.63 | -1.74 |
Cash Interest Paid | 3.44 | 5.18 | 4.45 | 4.16 | 3.97 |
Cash Income Tax Paid | 1.6 | 1.8 | 2 | 0.61 | 0.31 |
Levered Free Cash Flow | -1.37 | 2.36 | -11.53 | -4.51 | -4.9 |
Unlevered Free Cash Flow | 0.78 | 5.61 | -8.73 | -1.9 | -2.28 |
Change in Working Capital | 15.18 | 3.09 | -15.15 | 3.46 | -8.53 |